Evan Loh
Chief Executive Officer at PARATEK PHARMACEUTICALS, INC.
Net worth: 4 457 $ as of 2023-08-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Gregory L. Merril | M | - |
Adaptive Phage Therapeutics, Inc.
Adaptive Phage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Adaptive Phage Therapeutics, Inc. provides therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria. The company was founded by Gregory L. Merril and Carl R. Merril and is headquartered in Bethesda, MD. | 8 years |
Thomas Dietz | M | 60 | 10 years | |
David Apelian | M | 59 | 7 years | |
James Vollins | M | 55 | 1 years | |
Jonathan Light | M | - | 7 years | |
Carl R. Merril | M | - |
Adaptive Phage Therapeutics, Inc.
Adaptive Phage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Adaptive Phage Therapeutics, Inc. provides therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria. The company was founded by Gregory L. Merril and Carl R. Merril and is headquartered in Bethesda, MD. | 8 years |
Randy Brenner | M | 51 | 25 years | |
Adam Woodrow | M | 57 | 10 years | |
Helen Hobbs | M | 71 | 13 years | |
Robert Scott | M | 70 | 3 years | |
Kim Sablich | F | 55 | 3 years | |
Mikael Dolsten | M | 65 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | 16 years |
Amit Sachdev | M | 56 | 5 years | |
Leslie Williams | F | 64 | 3 years | |
Jonathan Leff | M | 55 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO.
Adaptive Phage Therapeutics, Inc.
Adaptive Phage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Adaptive Phage Therapeutics, Inc. provides therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria. The company was founded by Gregory L. Merril and Carl R. Merril and is headquartered in Bethesda, MD. | 6 years |
Lisa Kelly-Croswell | F | 57 | 2 years | |
Christopher Bostrom | M | - | 4 years | |
Diane Carman | F | 55 | 3 years | |
Jana Jensen | M | - |
Adaptive Phage Therapeutics, Inc.
Adaptive Phage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Adaptive Phage Therapeutics, Inc. provides therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria. The company was founded by Gregory L. Merril and Carl R. Merril and is headquartered in Bethesda, MD. | 3 years |
Karen McGrath | F | - | 5 years | |
Denis Patrick | M | - | 14 years | |
Susan M. Perkins | F | - | - | |
Jesse Goodman | M | 72 |
Adaptive Phage Therapeutics, Inc.
Adaptive Phage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Adaptive Phage Therapeutics, Inc. provides therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria. The company was founded by Gregory L. Merril and Carl R. Merril and is headquartered in Bethesda, MD. | 3 years |
Raj Padmanabhan | M | - | 9 years | |
Raymond Martz | M | 53 |
Adaptive Phage Therapeutics, Inc.
Adaptive Phage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Adaptive Phage Therapeutics, Inc. provides therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria. The company was founded by Gregory L. Merril and Carl R. Merril and is headquartered in Bethesda, MD. | - |
Stacey Seltzer | F | 47 | 1 years | |
Colin Hislop | M | 66 | - | |
Christopher Kurtz | M | 57 | 2 years | |
Richard A. Franco | M | - | 8 years | |
Adam Dilluvio | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Bernard Poussot | M | 72 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | 23 years |
Robert Essner | M | 76 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | 11 years |
William Steere | M | 88 | 28 years | |
Jeffrey Kindler | M | 68 | 8 years | |
Beverly A. Armstrong | F | 55 | - | |
Joseph M. Mahady | M | 71 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | 8 years |
R. Carruthers | M | 66 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 2 years |
William Haskel | M | 63 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | - |
David Cory | M | 60 | 14 years | |
Robert Landry | M | 60 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | 6 years |
Sriram Ryali | M | 43 | 5 years | |
Sebastian Mirkin | M | 52 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | 8 years |
John C. Kelly | M | 81 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | 8 years |
Eldon Mayer | M | 62 | 6 years | |
Jeffrey Glenn | M | 61 | 16 years | |
Jon Congleton | M | 60 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 3 years |
Stephana Patton | M | 54 | 2 years | |
Ingrid Choong | M | - | 15 years | |
Erik Atkisson | M | 52 | 2 years | |
Kate Wold | F | 71 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | 7 years |
John Leone | M | 77 | 9 years | |
Benjamin J. Strain | M | - | 3 years | |
Timothy Franson | M | 72 | 8 years | |
Marc Tessier-Lavigne | M | 64 | 4 years | |
Cynthia Smith | F | 55 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 1 years |
Richard Lim | M | 52 | 4 years | |
Christine Coyne | F | 55 | 4 years | |
Robert Radie | M | 60 | 9 years | |
Minnie Baylor-Henry | F | 76 | 2 years | |
Kristine Peterson | F | 64 | 7 years | |
Douglas Pagán | M | 52 | 5 years | |
Judith N. Steenbergen | M | - | - | |
John Moore | M | 59 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 5 years |
Brian Schreiber | M | 70 | 3 years | |
Jeffrey Stein | M | 69 | 9 years | |
Kenneth J. Martin | M | 70 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | 23 years |
Paul Sekhri | M | 66 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 1 years |
Charles Bramlage | M | 63 | 2 years | |
Robert N. Burt | M | 86 | 11 years | |
Dana George Mead | M | 88 | 12 years | |
Walter A. Gilbert | M | 92 | 18 years | |
Edgar Engleman | M | 78 | 1 years | |
Michael Bigham | M | 66 | 9 years | |
Christine Murray | F | 63 | 5 years | |
James Welch | M | 66 | 2 years | |
Bruce Peacock | M | 72 | 11 years | |
Sarah Higgins | F | 48 | - | |
Rolf K. Hoffmann | M | 64 | 5 years | |
Jim Shaffer | M | 57 | 7 years | |
Geno Germano | M | 63 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | 32 years |
Alex Goldsmith | M | - | 7 years | |
Santiago Arroyo | M | 64 | 5 years | |
Clare Khan | M | 72 | 6 years | |
Paulash Mohsen | M | - | 14 years | |
Hong I. Wan | M | - | 5 years | |
Robyn Peters | F | - | 4 years | |
Neil Gibson | M | 67 | 4 years | |
Dieter Weinand | M | 63 | 3 years | |
Marc Stapley | M | 54 | 3 years | |
Anna Berkenblit | M | 54 | 4 years | |
David Simmons | M | 59 | 16 years | |
Tom Sokolowski | M | - |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | - |
Angela Rossetti | F | 71 | 5 years | |
Cavan Redmond | M | 63 | 3 years | |
John Hubbard | M | 67 | 5 years | |
Scott R. Shively | M | 67 | 3 years | |
Regina M. DeTore Paglia | F | - | 4 years | |
John Henderson | M | 79 | - | |
Kim Seth | M | - | 3 years | |
Irina Apostolou | M | - | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Evan Loh
- Personal Network